Literature DB >> 3455692

Steroid inhibitory effects upon human adrenal 3 beta-hydroxysteroid dehydrogenase activity.

G C Byrne, Y S Perry, J S Winter.   

Abstract

The inhibitory effects of varying concentrations of steroids upon 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD) kinetics were studied in human adrenal microsomes. Each enzyme assay was conducted in triplicate at five different concentrations of three substrates (dehydroepiandrosterone, pregnenolone, and 17OH-pregnenolone), using microsomes from at least three donors. Each steroid was screened for possible inhibition at concentrations of 10(-8) and 10(-6) M and then studied in more detail at five different concentrations. The type of inhibition and the inhibition constant (Ki) were determined by analysis of Lineweaver-Burk and Dixon plots, together with replots of the slopes from the Dixon plots. The mean Km (Michaelis-Menten constant) for the three substrates was 0.42 +/- 0.04 (SE) mumol/liter (n = 73). Each steroid tested, including delta 5-3 beta-hydroxysteroids, estrogens, and several delta 4-3-ketosteroids, with the exception of cortisol, caused significant inhibition of 3 beta-HSD activity, and in each case the steroid appeared to behave as a competitive inhibitor. In most cases the Ki value was approximately 10(-7) M. At micromolar concentrations several steroids, notably estrone and estradiol, caused almost total inhibition of adrenal 3 beta-HSD activity. Comparison of the calculated Ki values with available data concerning changes in intra-adrenal steroid concentrations during childhood suggests that these changes would be sufficient to cause a relative decline in 3 beta-HSD activity during adrenarche. Although postnatal circulating steroid concentrations would appear to be insufficient to influence adrenal steroidogenesis, the high serum levels of placental steroids during fetal life would be expected to cause marked 3 beta-HSD inhibition.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3455692     DOI: 10.1210/jcem-62-2-413

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Long-term infertility in late-onset 3 beta-ol-dehydrogenase deficiency: successful pregnancy following dexamethasone and in vitro fertilization (IVF) therapy.

Authors:  N Rojansky; A Shushan; A Rosler; D Weinstein; N Laufer
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-10

Review 2.  A New Model for Adrenarche: Inhibition of 3β-Hydroxysteroid Dehydrogenase Type 2 by Intra-Adrenal Cortisol.

Authors:  Joseph A Majzoub; Lisa Swartz Topor
Journal:  Horm Res Paediatr       Date:  2018-05-30       Impact factor: 2.852

3.  New reliable biochemical marker for screening 21 alpha-hydroxylase deficiency without index person among hirsute women in agreement with HLA-haplotyping.

Authors:  A Chryssikopoulos; I Phocas; A Sarandakou; E Trakakis; D Rizos
Journal:  J Endocrinol Invest       Date:  1995-11       Impact factor: 4.256

Review 4.  The steroid metabolome of adrenarche.

Authors:  Juilee Rege; William E Rainey
Journal:  J Endocrinol       Date:  2012-06-19       Impact factor: 4.286

Review 5.  Adrenal androgens and androgen precursors-definition, synthesis, regulation and physiologic actions.

Authors:  Adina Turcu; Joshua M Smith; Richard Auchus; William E Rainey
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

6.  Cortisol stimulates secretion of dehydroepiandrosterone in human adrenocortical cells through inhibition of 3betaHSD2.

Authors:  Lisa Swartz Topor; Masato Asai; James Dunn; Joseph A Majzoub
Journal:  J Clin Endocrinol Metab       Date:  2010-10-13       Impact factor: 5.958

7.  The impact of peri-operative dexamethasone administration on the normal hypothalamic pituitary adrenal response to major surgical procedures.

Authors:  Katia El-Sibai; Aman Rajpal; Ribal Al-Aridi; Warren R Selman; Baha M Arafah
Journal:  Endocrine       Date:  2017-09-01       Impact factor: 3.633

8.  The effect of flutamide on basal and ACTH-stimulated plasma levels of adrenal androgens in patients with advanced prostate cancer.

Authors:  S Balzano; M Cappa; R Migliari; R M Scarpa; E Danielli; G Campus; C Pintus; V Sica; E Usai; E Martino
Journal:  J Endocrinol Invest       Date:  1988-11       Impact factor: 4.256

9.  Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy.

Authors:  Zhenfei Li; Mohammad Alyamani; Jianneng Li; Kevin Rogacki; Mohamed Abazeed; Sunil K Upadhyay; Steven P Balk; Mary-Ellen Taplin; Richard J Auchus; Nima Sharifi
Journal:  Nature       Date:  2016-05-26       Impact factor: 49.962

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.